Health Care News | Medical Research

Movies Fail to Portray CPR, Cardiac Arrest Accurately, Study Shows

Contemporary films portray cardiac arrest in a misleading fashion, according to authors of a study presented at ACC.25.

“As media plays a significant role in shaping public perception of health, film depictions of these life-saving measures may be important for informing public understanding of cardiac arrest and bystander action,” the investigators noted. They sought to analyze the portrayal of out-of-hospital cardiac arrest (OHCA) and CPR in popular film.

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Leah LawrenceTriple-Negative Breast Cancer | April 15, 2025

Sacituzimab govitecan showed modest CNS activity in pretreated HER2-negative metastatic breast cancer with brain metastases.

Long-Term, Short-Term Inhaled Corticosteroid Exposure Outcomes in Chronic Obstructive Pulmonary Disease

Jordana JampelPulmonology | April 15, 2025

Primary outcomes included new diagnosis of diabetes, cataracts, pneumonia, osteoporosis, or nontraumatic fractures.

Novel Cell Therapy Product for Bone Marrow Failure Syndromes Receives FDA Aplastic Anemia Orphan Drug Designation

Andrew MorenoAnemia | April 15, 2025

In a phase 1 trial the product performed favorably in aplastic anemia, myelofibrosis, and hypoplastic myelodysplasia.

Atrial Fibrillation Clinical Trials Suffer From Gender Disparities

Rob DillardACC.25 | April 15, 2025

Gender disparities persist in clinical trials related to atrial fibrillation (AF) management.

Genetic Testing for APOL1 Variants to Identify Kidney Disease Risk

Keightley Amen, BA, ELSNephrology Times | April 15, 2025

Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit.

Helping Patients With Kidney Disease Navigate Insurance Coverage

Keightley Amen, BA, ELSNephrology Times | April 15, 2025

At the NephCure Patient Summit, Montrez Lucas presented a session on how people with kidney disease can navigate insurance.

Encouraging Patients to Participate in Kidney Disease Clinical Trials

Keightley Amen, BA, ELSNephrology Times | April 15, 2025

Dr. Purva Sharma educated patients with kidney disease about clinical trials in a NephCure 2025 Patient Summit session.

Educational Session Offers Strategies to Address Mental Health Effects of Kidney Disease

Keightley Amen, BA, ELSNephrology Times | April 15, 2025

Social worker Janay Thompson shared mental health tips for patients with kidney disease at the NephCure 2025 Patient Summit.

DocWire Content Partners

CardioNerds

Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.

The Fellow on Call

Fundamentals, core concepts, and important management approaches in the field of hematology and oncology

Healthcare Unfiltered

Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.

The Oncology Brothers

Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.

Practice Tips With Dr. Lichaa

Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.

Rheumatology Rounds With Dr. Maheswaranathan

Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.

Powered by DocWire News

GI Oncology Now is the leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies, offering the latest study data and research breakthroughs related to colorectal, gastric, liver, pancreatic, and esophageal cancers.

Heme Today produces the latest news and research for hematologists and oncologists focused on blood disorders such as clotting, red and white blood cell, and iron disorders, including conference highlights, late-breaking research, interviews with leaders in the field, and more.

A medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and data analysis to inform providers on the latest research and most effective clinical practices in the lung cancers space.

Nephrology Times delivers the latest news in nephrological treatments and technologies, curating content from clinical trials, conference highlights, and perspectives from key opinion leaders, with the goal of better informing care decisions and improving patient outcomes.

The Latest From GI Oncology Now

Suvemcitug Combination Shows Promise in MSS/pMMR Colorectal Cancer

Emily MenendezColorectal Cancer | March 17, 2025

Suvemcitug, envafolimab, and FOLFIRI may serve as a new second-line treatment option for cold tumors.

Genetic Resistance to KRASG12C Inhibitors in CRC and PDAC

Emily MenendezPancreatic Cancer | March 17, 2025

KRASG12C inhibitors can have reduced efficacy in patients with alterations in KRAS, EGFR, and other genes.

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

Emily MenendezLiver Cancer | March 14, 2025

Complete responders with HCC have prolonged survival and durable disease control even after therapy has been discontinued.

177Lu-edotreotide Improves PFS, OS Over Everolimus for SSTR-Positive GEP-NETs

Emily MenendezGEP-NETs | March 12, 2025

The primary objective of median PFS was significantly longer for patients treated with 177Lu-edotreotide.

MATTERHORN: Durvalumab Plus FLOT Improves EFS and pCR in Gastric, GEJ Cancers

Emily MenendezGastroesophageal Cancer | March 12, 2025

The safety profile of the combination was consistent with known profiles, and no new safety findings were observed.

Risk for Choledocholithiasis Higher in Older Adult Patients With Cholangiocarcinoma

Emily MenendezBile Duct Cancer | March 11, 2025

Older patients in their 70s with extrahepatic CCA have a higher rate of choledocholithiasis.

The Latest From Heme Today

Novel Cell Therapy Product for Bone Marrow Failure Syndromes Receives FDA Aplastic Anemia Orphan Drug Designation

Andrew MorenoAnemia | April 15, 2025

In a phase 1 trial the product performed favorably in aplastic anemia, myelofibrosis, and hypoplastic myelodysplasia.

Reduced-Dose Apixaban Anticoagulation Noninferior to Full Dose in Prevention of Cancer-Associated VTE

Andrew MorenoVTE | April 15, 2025

The reduced-dose oral regimen also had lower incidence of clinically relevant bleeding complications and mortality rate.

Biotechnology Company Grants Commercial License for Cell Manufacturing Platform Use to Advance SCD Therapy

Andrew MorenoSickle Cell Disease | April 8, 2025

The platform features incubation technology able to replicate cell microenvironments associated with SCD sickling.

Investigational BTK Inhibitor Receives FDA Orphan Drug Designation For 2 Rare Diseases

Melissa BadamoHematology | April 7, 2025

The FDA granted orphan drug designation to rilzabrutinib for warm autoimmune hemolytic anemia and and IgG4-related disease.

ASH Bridge Grant Expands Award Eligibility to Advance Hematology Research

Ivan Maillard, MD, PhDHematology | April 8, 2025

ASH Awards Commitee Chair Ivan Maillard, MD, PhD, and prior awardee Rinku Majumder, PhD, tell of the Grant's positive impact.

FDA Grants Orphan Drug Designation to Bexobrutideg for Waldenström Macroglobulinemia

Melissa BadamoHematology | April 3, 2025

Bexobrutideg, an orally bioavailable, brain-penetrant BTK degrader, is being evaluated in a phase 1a/b study.

Expert Interviews

Network Websites

GU Oncology Now delivers the latest news in genitourinary oncology therapeutics, clinical trials, conference coverage, and research data, highlighting important advancements in treatments and technologies to better inform providers' decisions and improve patient outcomes.

Blood Cancers Today provides hematologists and oncologists with news, education, and research relevant to their patients and practices. Featuring the latest clinical updates from all facets of the specialty, it offers insights and exclusive interviews from experts in the field.

Cancer Nursing Today delivers critical news, research, and commentary to support oncology nurses throughout their education and careers. Its goal is to advance oncology treatments and care practices and promote the nurse’s role in enhanced patient outcomes and quality of life.

MashupMD is an innovative medical news and social media aggregator. The platform is optimized to deliver rapid access to the latest headlines in health care and collections of key medical content based on what health care professionals around the world are reading and sharing.

Urban Health Today is the leading independent news source that provides urban health care professionals with relevant research and policy developments that impact patients and their practices. Its coverage focuses on clinical, social, and environmental health disparities.